What is Oncology Analytics?
Oncology Analytics is a leading specialist in oncology care management, dedicated to assisting health plans, employers, oncologists, and patients in navigating the multifaceted challenges of cancer. The company's comprehensive cancer care management platform integrates utilization management, virtual cancer care support, and clinical consultations, aiming to drive success within value-based care models. This strategic focus positions Oncology Analytics at the forefront of innovation in cancer treatment and patient support.
How much funding has Oncology Analytics raised?
Oncology Analytics has raised a total of $81.5M across 4 funding rounds:
Series A
$7.5M
Series B
$21M
Private Equity
$25M
Series C
$28M
Series A (2016): $7.5M with participation from Sandbox Industries and The Blue Venture Fund
Series B (2018): $21M led by BlueCross BlueShield Venture Partners, Oak HC/FT, Sandbox Industries, and McKesson
Private Equity (2020): $25M supported by Undisclosed
Series C (2020): $28M featuring The Blue Venture Fund, Oak HC/FT, McKesson, and Baird Capital
Key Investors in Oncology Analytics
Oak HC/FT
Oak HC/FT is a premier venture growth-equity fund specializing in Healthcare Information & Services and Financial Services Technology. They provide strategic counsel and board-level participation to drive transformation in these industries.
McKesson
McKesson Corporation is a global leader in healthcare supply chain management solutions, pharmaceuticals, and medical supplies, offering a broad range of services to healthcare providers and payers.
Baird Capital
Baird Capital is a private equity and venture capital firm that invests in founder-led B2B tech and services companies globally, providing operational support and expertise to foster growth.
What's next for Oncology Analytics?
The recent major strategic investment signifies a pivotal moment for Oncology Analytics, likely enabling the company to accelerate its market expansion, enhance its technological infrastructure, and further develop its innovative cancer care solutions. This capital infusion is expected to bolster its position in the competitive healthcare landscape, facilitating deeper integration with health systems and payers to improve patient outcomes and manage the financial complexities of cancer care. The company's continued growth trajectory, supported by significant enterprise-level funding, suggests a strong commitment to advancing oncology services and solidifying its role in value-based healthcare.
See full Oncology Analytics company page
